Aluminium Waterproofing Membrane, Basic Waterproofing Membrane, HR Cap Sheet, ICF

Contains

Highly hydrotreated 64742-52-5 10-30 Not established naphthenic oil1 Calcium Carbonate1 471-34-1 0-40 10 mg/m³ Not established Styrene butadiene 9003-55-8 0-15 10 mg/m³ Not established copolymer1 REINFORCEMENT Some products may contain fibre glass, polyester or a mix of glass grid and polyester. Polyester mat1 N/A 1-7 Not established Fibre glass mat1 N/A 1-7 Not established 1 f/cc (for fibres longer than 5 Fibre glass filament1 65997-17-3 0.5-7 µm with a diameter of lower Not established than 3 µm) UNDERFACE AND SURFACE Some membranes are protected by sand, talc, mineral granule, silicone paper, polyethylene or polypropylene film, aluminium, copper or stainless steel foil. Silicone paper N/A 6-20 Not established Polypropylene film N/A 2-10 Not established Polyethylene film 9002-88-4 2-10 Not established Aluminium, copper or N/A 4-15 Not established stainless steel foil Sand N/A 7-13 0.1 mg/m³ Not established Crystalline silica² 14808-60-7 7-13 0.1 mg/m³ Not established 14807-96-6 7-13 2 mg/m³ Not established Talc Respirable particulate Coloured granules N/A 15-40 Not established Crystalline silica² 14808-60-7 < 12 0.1 mg/m³ Not established 1. The exposure to the product above the limits of exposure is not likely to occur considering its form (incorporated in the mixture) and the provided use. The limit of exposure is given for reference only. 2. A proportion of crystalline silica can be present in the sand sprinkled on the top of some membranes. The crystalline silica contained in the sand is not likely to be found in the ambient air in concentration above the limit of exposure since the sand adheres to the surface of the membrane.

Potential health effects

Effects of short term (acute) exposure SKIN CONTACT: The product can cause a mechanical irritation of the skin because of its rough surface. The asphalt fumes can cause an irritation of the skin. EYE CONTACT: The product is not likely to cause effects to the eyes. The asphalt fumes can cause irritations, redness and conjunctivitis to the eyes. INHALATION: The product is not likely to cause effects on the respiratory system. The asphalt fumes can cause irritations to the nose, the throat and the respiratory tracts, tiredness, headaches, dizziness, nauseas and insomnia. INGESTION: Exposure is not likely to occur by this route of entry under normal use of the product. Effects of long term (chronic) exposure SKIN CONTACT: The repeated or prolonged contact can cause irritation. The long-term exposure to the asphalt fumes can cause changes of the pigmentation of the skin which can be worsened by the exposure to the sun. (1) INHALATION: No data on chronic effects of the exposure to asphalt fumes on the lungs. CARCINOGENICITY: Due to the product form, exposure to hazardous dusts or fumes is not expected to occur. Information on carcinogenicity is given for r eference only. This product is not classifiable as a carcinogen. Asphalt: The International Agency for Research on Cancer (IARC) has concluded that this product is not classifiable as to its carcinogenicity to humans. Epidemiological studies of roofers have generally demonstrated an excess of lung cancer in these workers. However, it is unclear to what extent these cancers may be attributable to asphalt exposures during roofing operations, since in the past, roofers have been exposed to coal tar and asbestos, which are known human lung carcinogens. Although strong epidemiological evidence exists of an association between lung cancer and working as a roofer, it is uncertain whether exposure to asphalt is related to this association. Trace amounts of polynuclear aromatic hydrocarbons (PAHs) may be present in some asphalts and can be released upon excessive heating. Some o f these PAHs have been identified as having the potential to induce carcinogenic and reproductive health effects. (2) Crystalling Silica: Breathable crystalline silica from sand is not expected to be released, sand is adhered to product. Crystalline silica is considered a hazard by inhalation. The International Agency for Research on Cancer (IARC) classified crystalline silica in quartz form coming from professional exposure carcinogenic for human (Group 1). (3) Fibreglass Filament: Fibreglass is not expected to be released. In October 2001, IARC classified fibreglass as Group 3 “not classifiable as to its carcinogenicity to humans”. The 2001 decision was based on current human and animal research that shows no association between inhalation exposure to dust from fibreglass wool and the development of respiratory disease. This is a reversal of the IARC finding in 1987 of a Group 2B designation (possibly carcinogenic to humans) based on earlier studies in which animals were injected with large quantities of fibreglass. NTP and ACGIH have not yet reviewed the IARC reclassification of the most current fibreglass health research. At this time, both a gencies continue to classify glass wool based on the earlier animal injection studies. No information available about the other products.

Teratogenic Effects

EMBRIOTOXICITY, FETOTOXICITY No information available. REPRODUCTIVE TOXICITY: No information available. MUTAGENICITY: No information available. TOXICILOGICALLY SYNERGISTIC MATERIALS: No information available. POTENTIAL ACCUMULATION: No information available.